US Chamber Suffers Setback in Bid to Block Medicare Drug Talks (2)

The Medicare agency may continue implementing its drug price negotiation program even as litigation over the plans play out in federal court, a judge ordered Friday.

The US Chamber of Commerce and several affiliates haven’t demonstrated a “strong likelihood” of succeeding on their claim that the Inflation Reduction Act’s drug price negotiation provisions violate the due process clause of the Fifth Amendment, wrote Judge Michael J. Newman for the US District Court for the Southern District of Ohio. The Chamber, whose members include drugmaker AbbVie Inc., had used the due process argument as a basis for requesting a pause ...